Ceramide NanoLiposome in Patients With Advanced Solid Tumors
NCT02834611
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Carcinoma
Solid Tumors
Tumor
Interventions
DRUG:
Ceramide NanoLiposome
Sponsor
Keystone Nano, Inc
Collaborators
[object Object]
[object Object]